(Q33653631)

28 July 2017

1 reference

title

Local and systemic radiation for palliation of metastatic disease (English)

1 reference

28 July 2017

Friedland J

1

1 reference

28 July 2017

1 May 1999

1 reference

Urologic Clinics of North America

28 July 2017

1 reference

28 July 2017

26

1 reference

28 July 2017

2

1 reference

28 July 2017

391-402, x

1 reference

Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Selective accumulation of strontium-89 in metastatic deposits in bone: radio-histological correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Strontium-89 chloride for pain palliation in prostatic skeletal malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Painful bone metastasis: efficacy of radiotherapy assessed by the patients: a randomized trial comparing 4 Gy X 6 versus 10 Gy X 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

The use of radioactive phosphorus and testosterone in metastatic bone lesions from breast and prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

A retrospective analysis of the cost effectiveness of treatment with Metastron (89Sr-chloride) in patients with prostate cancer metastatic to bone

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

The palliation of osseous metastasis with 32P or 89Sr compared with external beam and hemibody irradiation: a historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Randomized prospective clinical study of small, large and twice-a-day fraction radiotherapy for painful bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Serum PICP as a bone formation marker in 89Sr and external beam radiotherapy of prostatic bony metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metast

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Strontium-89--precursor targeted therapy for pain relief of blastic metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Phosphorus-32 radiopharmaceuticals for the treatment of painful osseous metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

Strontium-89 combined with doxorubicin in the treatment of patients with androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970078-1

7 January 2021

10.1016/S0094-0143(05)70078-1

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10361561